NVCN

Neovasc (NVCN)

Neovasc Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:NVCN

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/08/03	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:NVCN	Neovasc Inc
2023/04/25	05 : 15	Edgar (US Regulatory)	Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities Under Section 12(b) (15f-12b)	NASDAQ:NVCN	Neovasc Inc
2023/04/13	02 : 11	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NVCN	Neovasc Inc
2023/04/11	22 : 19	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NVCN	Neovasc Inc
2023/04/11	22 : 11	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	NASDAQ:NVCN	Neovasc Inc
2023/04/11	22 : 08	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10pos)	NASDAQ:NVCN	Neovasc Inc
2023/04/11	22 : 07	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:NVCN	Neovasc Inc
2023/04/11	22 : 06	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:NVCN	Neovasc Inc
2023/04/11	21 : 48	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:NVCN	Neovasc Inc
2023/04/11	21 : 21	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NVCN	Neovasc Inc
2023/04/11	21 : 20	GlobeNewswire Inc.	Shockwave Medical Completes Acquisition of Neovasc	NASDAQ:NVCN	Neovasc Inc
2023/04/01	05 : 11	GlobeNewswire Inc.	Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update	NASDAQ:NVCN	Neovasc Inc
2023/03/10	06 : 26	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NVCN	Neovasc Inc
2023/03/07	20 : 09	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NVCN	Neovasc Inc
2023/03/07	07 : 37	GlobeNewswire Inc.	Neovasc Shareholders Approve Acquisition by Shockwave Medical	NASDAQ:NVCN	Neovasc Inc
2023/02/11	06 : 08	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NVCN	Neovasc Inc
2023/02/01	23 : 07	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NVCN	Neovasc Inc
2023/02/01	23 : 05	GlobeNewswire Inc.	Neovasc Announces German Reimbursement Renewal	NASDAQ:NVCN	Neovasc Inc
2023/01/28	06 : 06	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NVCN	Neovasc Inc
2023/01/17	23 : 29	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NVCN	Neovasc Inc
2023/01/17	22 : 00	GlobeNewswire Inc.	Shockwave Medical to Acquire Neovasc	NASDAQ:NVCN	Neovasc Inc
2023/01/17	22 : 00	GlobeNewswire Inc.	Shockwave Medical Announces Agreement to Acquire Neovasc	NASDAQ:NVCN	Neovasc Inc
2022/11/29	06 : 45	GlobeNewswire Inc.	Neovasc Announces Progress on COSIRA-II Clinical Trial	NASDAQ:NVCN	Neovasc Inc
2022/11/18	23 : 07	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NVCN	Neovasc Inc
2022/11/18	23 : 05	GlobeNewswire Inc.	Neovasc Comments on European Heart Journal Publication	NASDAQ:NVCN	Neovasc Inc
2022/11/15	20 : 45	TipRanks	H.C. Wainwright Sticks to Its Buy Rating for Neovasc (NVCN)	NASDAQ:NVCN	Neovasc Inc
2022/11/11	06 : 08	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NVCN	Neovasc Inc
2022/11/11	06 : 05	GlobeNewswire Inc.	Neovasc Announces Third Quarter Financial Results and Provides Corporate Update	NASDAQ:NVCN	Neovasc Inc
2022/11/08	23 : 05	GlobeNewswire Inc.	Neovasc Reducer Obtains U.S. Outpatient Reimbursement	NASDAQ:NVCN	Neovasc Inc
2022/10/27	22 : 04	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:NVCN	Neovasc Inc